An investment in BD involves a variety of risks and uncertainties that could adversely affect its business, financial condition, operating results, or cash flows. Global economic conditions could continue to adversely affect operations, resulting in decreased demand for products and services, increased competition, and downward pressure on prices. A weakening of macroeconomic conditions may also adversely affect suppliers, potentially resulting in interruptions in supply. The company is subject to foreign currency exchange risk, with a significant portion of revenues derived from international operations, which may be adversely affected by fluctuations in foreign currency exchange rates. Changes in reimbursement practices of third-party payers could affect demand for products and prices, impacting customer purchasing decisions. Federal healthcare reform may adversely affect results of operations, with the Patient Protection and Affordable Care Act imposing an excise tax on U.S. sales of certain medical devices, potentially reducing demand and increasing pricing pressure. Consolidation in the healthcare industry could adversely affect future revenues and operating income, increasing competition and pricing pressure. Cost volatility could negatively impact operations, particularly with respect to raw materials and energy costs, which may not be offset through other cost reductions. Breaches of information technology systems could have a material adverse effect on operations, as the company relies on these systems for processing and storing electronic information. The future growth of BD is dependent on the development of new products, which requires significant investment in research and development, clinical trials, and regulatory approvals. The company's ability to anticipate customer needs and innovate is critical for maintaining competitive advantage. The medical technology industry is highly competitive, subject to rapid technological change, and characterized by changing customer preferences. The international operations of BD expose it to risks including local economic conditions, regulatory requirements, and potential political instability. The company must attract and retain key employees to remain competitive, as competition for experienced talent is intense. The integration of acquisitions poses risks, including the potential loss of key employees and the challenge of successfully combining operations. The company continues to pursue growth opportunities in emerging markets, which depend on local economic and political conditions. The ability to sustain long-term growth is influenced by various factors, including the expansion of core business, development of innovative products, and improvement of operational efficiency. BD's financial position remains strong, with significant cash flows from operating activities, although ongoing economic challenges may impact future performance. The company faces various legal proceedings that could have a material adverse effect on results of operations and cash flows. The management of BD is focused on delivering sustainable growth and shareholder value while making appropriate investments for the future, with a strategy that includes improving operating effectiveness and balancing productivity. The company is committed to enhancing its organizational capabilities to adapt to changing market conditions and maintain resilience in the face of external pressures.